Literature DB >> 24322484

Facilitating Alzheimer disease research recruitment.

Joshua D Grill1, James E Galvin.   

Abstract

Alzheimer disease (AD) research faces challenges to successful enrollment, especially to clinical trials and biomarker studies. Failure to recruit the planned number of participants in a timely manner threatens the internal validity and success of clinical research, raising concerns about external validity and generalizability of results, and possibly leading to disparities in disease treatment. Methods to improve recruitment exist, but require varying levels of staff effort and financial resources, and evidence of effectiveness is often lacking or inconsistent. In this review, we summarize some of the available methods to improve AD research recruitment, the available literature to support or refute these strategies, and some of the experiences at the authors' AD Research Centers. We discuss the use of community-based participatory research principles and participant registries as a means to enhance research enrollment and increase diversity of research samples.

Entities:  

Mesh:

Year:  2014        PMID: 24322484      PMCID: PMC3945167          DOI: 10.1097/WAD.0000000000000016

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  60 in total

Review 1.  Issues of race, ethnicity, and culture in caregiving research: a 20-year review (1980-2000).

Authors:  Peggye Dilworth-Anderson; Ishan Canty Williams; Brent E Gibson
Journal:  Gerontologist       Date:  2002-04

2.  Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience.

Authors:  Annette L Fitzpatrick; Linda P Fried; Jeff Williamson; Patricia Crowley; Delilah Posey; Linly Kwong; Janet Bonk; Roberta Moyer; Joyce Chabot; Lara Kidoguchi; Curt D Furberg; Steven T DeKosky
Journal:  Contemp Clin Trials       Date:  2006-07-04       Impact factor: 2.226

3.  ResearchMatch: a national registry to recruit volunteers for clinical research.

Authors:  Paul A Harris; Kirstin W Scott; Laurie Lebo; Niknik Hassan; Chad Lightner; Jill Pulley
Journal:  Acad Med       Date:  2012-01       Impact factor: 6.893

4.  Evaluation of community-academic partnership functioning: center for the elimination of hepatitis B health disparities.

Authors:  Nancy VanDevanter; Simona Kwon; Shao-Chee Sim; Kay Chun; Chau Trinh-Shevrin
Journal:  Prog Community Health Partnersh       Date:  2011

Review 5.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial).

Authors:  I Carrié; G Abellan van Kan; S Gillette-Guyonnet; S Andrieu; J-F Dartigues; J Touchon; T Dantoine; O Rouaud; M Bonnefoy; P Robert; M-N Cuffi; L Bories; S Bordes; Y Gasnier; F Desclaux; K Sudres; A Pesce; B Vellas
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

7.  Seeking a diagnosis for memory problems: the experiences of caregivers and families in 5 limited English proficiency communities.

Authors:  Darby Morhardt; Marta Pereyra; Madelyn Iris
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

8.  Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail.

Authors:  Fred Andersen; Torgeir A Engstad; Bjørn Straume; Matti Viitanen; Dag S Halvorsen; Samuel Hykkerud; Kjell Sjøbrend
Journal:  BMC Med Res Methodol       Date:  2010-04-29       Impact factor: 4.615

9.  Research subject recruitment for gerontological studies of pharmacological agents.

Authors:  M I Levy; R C Mohs; W G Rosen; K L Davis
Journal:  Neurobiol Aging       Date:  1982       Impact factor: 4.673

10.  Chronic disease long-term drug prevention trials: lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).

Authors:  Curtis L Meinert; John C S Breitner
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

View more
  46 in total

1.  Cerebral β-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's Disease.

Authors:  Eric D Vidoni; Hung-Wen Yeh; Jill K Morris; Kathy L Newell; Abdulfattah Alqahtani; Nicole C Burns; Jeffrey M Burns; Sandra A Billinger
Journal:  Neurodegener Dis       Date:  2016-01-13       Impact factor: 2.977

2.  GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.

Authors:  Jessica B Langbaum; Jason Karlawish; J Scott Roberts; Elisabeth M Wood; Angela Bradbury; Nellie High; Trisha L Walsh; David Gordon; Raj Aggarwal; Peter Davis; Carter Stowell; Lane Trisko; Carolyn M Langlois; Eric M Reiman; Pierre N Tariot
Journal:  Alzheimers Dement       Date:  2019-02-13       Impact factor: 21.566

3.  Attitudes toward Potential Participant Registries.

Authors:  Joshua D Grill; Andrew Holbrook; Aimee Pierce; Dan Hoang; Daniel L Gillen
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.

Authors:  Irving E Vega; Laura Y Cabrera; Cassandra M Wygant; Daniel Velez-Ortiz; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach.

Authors:  Alon Seifan; Christine A Ganzer; Francoise Vermeylen; Stephen Parry; Jifeng Zhu; Abigail Lyons; Richard Isaacson; Sarang Kim
Journal:  J Public Health (Oxf)       Date:  2017-12-01       Impact factor: 2.341

6.  Alzheimer Disease Clinical Trial Recruitment: Does Participation in a Brief Cognitive Screen at a Community Health Fair Promote Research Engagement?

Authors:  Justin M Barber; Shoshana H Bardach; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

7.  Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.

Authors:  Joshua D Grill; Yan Zhou; David Elashoff; Jason Karlawish
Journal:  Neurobiol Aging       Date:  2015-11-22       Impact factor: 4.673

8.  Obstacles and opportunities in Alzheimer's clinical trial recruitment.

Authors:  Jennifer L Watson; Laurie Ryan; Nina Silverberg; Vicky Cahan; Marie A Bernard
Journal:  Health Aff (Millwood)       Date:  2014-04       Impact factor: 6.301

9.  Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network.

Authors:  J Cummings; P Aisen; R Barton; J Bork; R Doody; J Dwyer; J C Egan; H Feldman; D Lappin; L Truyen; S Salloway; R Sperling; G Vradenburg
Journal:  J Prev Alzheimers Dis       Date:  2016-03-04

10.  Attitudes and Perceptions of Research in Aging and Dementia in an Urban Minority Population.

Authors:  Judith Neugroschl; Margaret Sewell; Angelica De La Fuente; Mari Umpierre; Xiaodong Luo; Mary Sano
Journal:  J Alzheimers Dis       Date:  2016-04-23       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.